Drug intelligence / Profile preview

hops

Development stage
Unknown
Lead developer
Max Zeller Söhne
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hops (*Humulus lupulus* L.) strobile extract is a botanical medicine derived from the female flowers of the hop plant. It is primarily used for its sedative and sleep-promoting properties, often as a component of phytotherapeutic products such as Ze 91019 (a fixed combination with valerian root extract developed by Max Zeller Söhne AG). The hops component acts as a melatonin receptor agonist, helping to regulate circadian rhythms and reduce sleep latency. It is indicated for the treatment of nonorganic insomnia and nonorganic disorders of the sleep-wake schedule. Clinical evaluations, including Phase III trials, have demonstrated its efficacy both as a mono-extract and in combination therapies, showing good tolerability without the 'hangover' effects or habituation associated with synthetic sedatives.

Other names
Humulus lupulushops strobile extractHumulus lupulus L. strobile extract
02

Targets

MTNR1A (MT1)MTNR1B (Melatonin Receptor 2)ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)5-HT4e (5-hydroxytryptamine receptor 4 isoform e)HTR6 (5-hydroxytryptamine receptor 6)GABRR (GABA-A receptor subunit rho)HTR7 (5-hydroxytryptamine receptor 7)

Beyond the preview

Go deeper on hops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hops.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call